Should I buy Crocs (CROX) stock or is it too late?

Crocs · Consumer Discretionary · price $122

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 62% of its targets hit on this sector (213 calls tested). It aims for $120 (-1.4 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).

The 2 reliable analysts $140+15 %

The 6 other firms $141+16 %

How to read it: the 2 reliable firms are not filtered by optimism — 1 aim above the price, 1 below, hence their $140 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Crocs

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Loop Capital	60 %	+60.8 %	5	$110 -10%
Piper Sandler	53 %	+40.0 %	15	$150 +23%
Baird	33 %	+23.3 %	9	$150 +23%
Needham	40 %	+10.5 %	5	$132 +8%
Wedbush	62 %	+9.6 %	13	$170 +40%
Stifel	45 %	+3.3 %	11	$125 +3%
B of A Securities	43 %	+2.7 %	7	$160 +31%
Keybanc	20 %	-6.5 %	5	$95 -22%

In short — Should you invest in Crocs? Is it too late, still worth it? Analysts are fairly positive (56% buy, median target $141, i.e. +16%), and the most reliable on CROX targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $141, i.e. +16% from the current price ($122).
The most reliable firm on CROX, Piper Sandler (53% hit rate, 15 scored calls), targets $150 (call made on June 26, 2026, maturing on June 26, 2027) (+23%) in its most recent call, and $75 (call made on September 22, 2025, maturing on September 22, 2026) (-38%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 4 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on CROX

Median target $141 (+16%) · 9 ratings · Buy consensus

Strong Buy00%

Buy556%

Hold444%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Crocs now?

We won't decide for you. The facts: 56% of analysts rate it a buy, median target $141 (+16%), and Piper Sandler (most reliable on CROX, 53%) targets $150. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Crocs?

Not according to analysts: the median target ($141) is still +16% above the current price ($122) (most reliable on CROX: Piper Sandler, 53%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Crocs still worth investing in?

It depends on the gap between the price ($122) and its estimated value: analysts target $141 on median (+16%), with 56% buys (most reliable on CROX: Piper Sandler, 53%). Cross-check with their real reliability on CROX and the cautions above. Information, not advice.

What's the main risk in buying CROX?

The consensus is not unanimous: of 9 ratings, 4 are neutral.

→ Go deeper: the full Crocs profile (consensus, analyst reliability, price target, performance).